LRRK2 and Parkinson disease: Performing genetic screening in a cohort of 94 DBS-treated PD patients, Angeli et al. identified parkin, LRRK2 or GBA mutations in 29%.20 No mutations were found in SNCA, PINK1 or DJ-1.